Exploring the eligibility of all reported lipoarabinomannan-testing assays in different clinical situations: a systematic review and meta-analysis of 97 articles-Reference-Cited by-同舟云学术

Exploring the eligibility of all reported lipoarabinomannan-testing assays in different clinical situations: a systematic review and meta-analysis of 97 articles

Published:2022-12 Issue: Volume:125 Page:19-34
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Lyu Mengyuan,Zhou Yanbing,Chen Yi,Lai Hongli,Wang Yili,Cheng Yuhui,Li Jing,Peng Wu,Liu Tangyuheng,Jiang Xin,Li Mei,Zhao Zhenzhen,Ying Binwu

Funder

West China Hospital, Sichuan University

National Science and Technology Program during the Twelfth Five-year Plan Period

Department of Science and Technology of Sichuan Province

Sichuan University

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. Detection of mycobacterial lipoarabinomannan in serum for diagnosis of active tuberculosis;Brock;Diagn Microbiol Infect Dis,2020

2. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression;Coppola;Tuberculosis (Edinb),2017

3. Lipoarabinomannan in active and passive protection against tuberculosis;Correia-Neves;Front Immunol,2019

4. Is urinary lipoarabinomannan the result of renal tuberculosis? Assessment of the renal histology in an autopsy cohort of Ugandan HIV-infected adults;Cox;PLoS One,2015

5. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection;Drain;Clin Microbiol Rev,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthrough of chemiluminescence-based LAM urine test beyond HIV-positive individuals: Clinical diagnostic value of pulmonary tuberculosis in the general population;Medicine;2023-12-01